New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
Authors
Keywords
Genetic, Molecular, Vaccine, Malaria, Adenovector, Adenovirus, Gorilla, Non-human primate, Single-administration, Efficacy
Journal
MALARIA JOURNAL
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-03
DOI
10.1186/s12936-017-1911-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
- (2015) Caroline Ogwang et al. Science Translational Medicine
- Cytotoxic Markers Associate With Protection Against Malaria in Human Volunteers Immunized WithPlasmodium falciparumSporozoites
- (2014) Else M. Bijker et al. JOURNAL OF INFECTIOUS DISEASES
- Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
- (2014) Martha Sedegah et al. PLoS One
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
- (2014) L. Swadling et al. Science Translational Medicine
- Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization
- (2013) K. M. Quinn et al. JOURNAL OF IMMUNOLOGY
- Genetic Vaccine for Respiratory Syncytial Virus Provides Protection Without Disease Potentiation
- (2013) Teresa R Johnson et al. MOLECULAR THERAPY
- Designing Tomorrow's Vaccines
- (2013) Gary J. Nabel NEW ENGLAND JOURNAL OF MEDICINE
- Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
- (2013) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
- (2013) Caroline Ogwang et al. PLoS One
- DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
- (2013) Ilin Chuang et al. PLoS One
- A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
- (2013) Neal N. Padte et al. PLoS One
- In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages
- (2013) I. A. Cockburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Adenoviruses isolated from wild gorillas are closely related to human species C viruses
- (2013) McVey Duncan et al. VIROLOGY
- Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
- (2013) Seleeke Flingai et al. Frontiers in Immunology
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
- (2012) Susanne H. Sheehy et al. PLoS One
- Protective CD8+ T lymphocytes in Primates Immunized with Malaria Sporozoites
- (2012) Walter R. Weiss et al. PLoS One
- Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses
- (2012) Joseph T. Bruder et al. PLoS One
- Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity
- (2012) D. E. Zak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
- (2012) S. Colloca et al. Science Translational Medicine
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Memory CD8 T Cells Specific for Plasmodia Liver-Stage Antigens Maintain Protracted Protection Against Malaria
- (2012) Urszula Krzych et al. Frontiers in Immunology
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates
- (2011) Keith Limbach et al. MALARIA JOURNAL
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
- (2011) Nancy J Sullivan et al. NATURE MEDICINE
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
- (2011) Cindy Tamminga et al. PLoS One
- A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
- (2011) David W. Porter et al. VACCINE
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
- (2011) Dan H. Barouch et al. VACCINE
- Prime-boost vectored malaria vaccines: Progress and prospects
- (2010) Adrian V. S. Hill et al. Human vaccines & immunotherapeutics
- A retrospective evaluation of the role of T cells in the development of malaria vaccine
- (2009) Moriya Tsuji EXPERIMENTAL PARASITOLOGY
- Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
- (2009) Zhou Xing et al. PLoS One
- Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies
- (2009) George Jiang et al. PLoS One
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Protective CD8+T cells againstPlasmodiumliver stages: immunobiology of an ‘unnatural’ immune response
- (2008) Michael Glen Overstreet et al. IMMUNOLOGICAL REVIEWS
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search